MyFinsight
Home
Blog
About
Back
Income Statement
Cullinan Therapeutics, Inc. (CGEM)
Cullinan Therapeutics, Inc. (CGEM)
source: myfinsight.com
Comprehensive loss
-$53,965K
(22.86%↑ Y/Y)
Interest income
$3,648K
Net loss
-$53,704K
(23.34%↑ Y/Y)
Unrealized gain (loss) on
investments
-$261K
(-355.88%↓ Y/Y)
Total other income
$3,550K
Other expense, net
-$98K
Loss from operations
-$57,254K
Total operating
expenses
$57,254K
Research and development
$44,437K
General and
administrative expense
$12,817K
Back